Corbus Pharmaceuticals Holdings, Inc. Notes Payable, Current
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Notes Payable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2025-03-11
- 2024-12-31: Notes Payable, Current $0.00.
- 2024-09-30: Notes Payable, Current $0.00.
- 2024-06-30: Notes Payable, Current $77.00K.
- 2024-03-31: Notes Payable, Current $189.82K.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $77.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $189.82K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $301.00K 10-K · filed 2025-03-11 | $300.66K 10-K · filed 2024-03-12 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $51.16K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $203.26K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $353.32K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $110.70K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $440.81K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $767.94K 10-K · filed 2023-03-07 | |
| 2021-06-30 | $102.69K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $408.28K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $710.16K 10-K · filed 2022-03-08 | |
| 2020-06-30 | $108.94K 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $432.90K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $752.66K 10-K · filed 2021-03-15 | |
| 2019-06-30 | $99.33K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $247.38K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $394.31K 10-K · filed 2020-03-16 | |
| 2018-06-30 | $83.70K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $208.65K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $332.86K 10-K · filed 2019-03-12 | |
| 2017-06-30 | $39.04K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $155.73K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $271.76K 10-K · filed 2018-03-12 | |
| 2016-06-30 | $23.33K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $92.96K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $162.02K 10-K · filed 2017-03-08 | |
| 2015-03-31 | $72.49K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $144.39K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $75.24K 10-Q · filed 2014-11-13 | |
| 2013-12-31 | $306.83K 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |